Michael Burry buys Zoetis (ZTS), sells Salesforce (CRM) and Autodesk (ADSK) positions

Michael Burry's strategic shift to buy Zoetis while selling positions in Salesforce and Autodesk indicates a belief in the pharmaceuticals sector over software, possibly reflecting a change in growth expectations. This move could also suggest Burry's view on the relative valuations and potential recovery in healthcare versus the tech sector's challenges, which might prompt other investors to reassess their own portfolios.